A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

NCT00454233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: YM543
DRUG: Metformin
DRUG: Placebo

Sponsor

Astellas Pharma Inc